LUNG CANCER BREAKTHROUGH: New drug can lead to 'unprecedented' reduction in tumours

LUNG CANCER BREAKTHROUGH: New drug can lead to 'unprecedented' reduction in tumours
 

Tagrisso (osimertinib) was granted a licence only in February and has been hailed as a “breakthrough” drug by manufacturer AstraZeneca.
The once-a-day tablet is suitable for patients with non-small-cell lung cancer who have a specific mutation that means they have stopped responding to earlier treatments.
Experts predict around 300 patients in England and Wales will be eligible for Tagrisso every year.
The National Institute for Health and Care Excellence (Nice) has issued final draft guidance that says Tagrisso should be made available through the Cancer Drugs Fund (CDF), after a financial... read more

 
5 October 2016 in Health, Views: 37
Share:
  •  





    News Widget for Webmasters



    Bring Eugene's son back home immediately

    Realtime News

     

    «
    »
    Mo Tu We Th Fr Sa Su
          1 2 3 4
    5 6 7 8 9 10 11
    12 13 14 15 16 17 18
    19 20 21 22 23 24 25
    26 27 28 29 30 31